Enter your email address to receive updates
Search By Trade Name
Trade name | Generic name | Classification
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z 
Generic Name
Docetaxel anhydrous
Trade Name
Taxotere
Manufacturer
Aventis Pharma
Risk Category
D
  • Positive evidence of human fetal risk exists.
  • Potential benefits may warrant use of the drug in pregnant women despite potential risks (e.g. life threatening situations or serious illness).
FDA Pregnancy Risk Categories

Place (not click) your mouse cursor over the bold words in the text below to receive description

Indication
Indication
  • antineoplastic agent.
  • Fetal Risk
    Fetal Risk
  • Crosses the placenta in animals.
  • Embryo and fetotoxic in animals at maternal toxic doses causing intrauterine death, fetal resorption, decreased fetal weight and delayed fetal ossification.
  • No human data and should be avoided during pregnancy and effective contraception is advised during therapy and at least 3 months after administration.
  • Breast Feeding
    Breast Feeding
  • Excreted into milk of lactating animals.
  • Unknown excretion into human milk, breast feeding is not recommended during chemotherapy.
  • Other Trade Names
     
    The information on this Web site is not intended as a substitute for the advice and care of your doctor or other health-care provider. Always consult your doctor if you have any questions about exposures during pregnancy and lactation, and before you take any medications. Please read the Terms and Conditions before using this website.
      Tell A Friend

        You
    Name
    Email
        Your Friend
    Name
    Email
        Comments
     7   +   5    =  
      Calculate Birth Date
    Enter the first day of the last menstruation
    Month Day Year
    Result
    Month Day Year